Voyager Therapeutics, Inc. (VYGR) Earnings Call Analysis

NASDAQ · Healthcare · Biotechnology

Earnings Reports

• Voyager Therapeutics (VYGR) Q3 2025: Tau Program Readouts and Multi-Modality Expansion Signal 2026 Pipeline Inflection
  November 12, 2025
• Voyager Technologies (VYGR) Q2 2025: Defense and National Security Revenue Surges 85%, Reinforcing Platform Leverage
  August 13, 2025
• Voyager Digital (VYGR) Q1 2025: $60M Capital Infusion Bolsters Liquidity Amid Crypto Volatility
  July 07, 2025

Browse all companies